dc.relation.reference | 1. PA. Rota, MS. Oberste, SS. Monroe, WA. Nix, R. Campagnoli, JP. Icenogle, S. Peñaranda, B. Bankamp, K. Maher, MH. Chen, S. Tong, A. Tamin, L. Lowe, M. Frace, JL. DeRisi, Q. Chen, D. Wang, DD. Erdman, TC. Peret, C. Burns, TG. Ksiazek, PE. Rollin, A. Sanchez, S. Liffick, B. Holloway, J. Limor, K. McCaustland, M. Olsen-Rasmussen, R. Fouchier, S. Günther, AD. Osterhaus, C. Drosten, MA. Pallansch, LJ. Anderson, WJ. Bellini. (2003) Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 300(5624): 1394-1399.
2. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 based on data as of the 31 December 2003. http://www.who.int/csr/sars/country/table2004_04_21/en/
3. PR. Hsueh, PC. Yang. (2005) Severe acute respiratory syndrome epidemic in Taiwan, 2003. J Microbiol Immunol Infect. 38(2): 82-88.
4. N. Lee, D. Hui, A. Wu, P. Chan, P. Cameron, GM. Joynt, A. Ahuja, MY. Yung, CB. Leung, KF. To, SF. Lui, CC. Szeto, S. Chung, JJ. Sung. (2003) A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 348(20): 1986-1994.
5. KW. Tsang, PL. Ho, GC. Ooi, WK. Yee, T. Wang, M. Chan-Yeung, WK. Lam, WH. Seto, LY. Yam, TM. Cheung, PC. Wong, B. Lam, MS. Ip, J. Chan, KY. Yuen, KN. Lai. (2003) A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 348(20): 1977-1985.
6. K. Stadler, V. Masignani, M. Eickmann, S. Becker, S. Abrignani, HD. Klenk, R. Rappuoli. (2003) SARS--beginning to understand a new virus. Nat Rev Microbiol. 1(3): 209-218.
7. HY. Sun, CT. Fang, JT. Wang, YC. Chen, SC. Chang. (2003) Treatment of severe acute respiratory syndrome in health-care workers. Lancet. 362(9400): 2025-2026.
8. S. Navas-Martín, SR. Weiss. (2004) Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development. J Neurovirol. 10(2): 75-85.
9. C. Drosten, S. Günther, W. Preiser, S. van der Werf, HR. Brodt, S. Becker, H. Rabenau, M. Panning, L. Kolesnikova, RA. Fouchier, A. Berger, AM. Burguière, J. Cinatl, M. Eickmann, N. Escriou, K. Grywna, S. Kramme, JC. Manuguerra, S. Müller, V. Rickerts, M. Stürmer, S. Vieth, HD. Klenk, AD. Osterhaus, H. Schmitz, HW. Doerr. (2003) Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 348(20): 1967-1976.
10. JS. Peiris, ST. Lai, LL. Poon, Y. Guan, LY. Yam, W. Lim, J. Nicholls, WK. Yee, WW. Yan, MT. Cheung, VC. Cheng, KH. Chan, DN. Tsang, RW. Yung, TK. Ng, KY. Yuen, and members of the SARS study group. (2003) Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 361:1319–1325.
11. RA. Fouchier, T. Kuiken, M. Schutten, G. van Amerongen, GJ. van Doornum, BG. van den Hoogen, M. Peiris, W. Lim, K. Stöhr, AD. Osterhaus. (2003) Aetiology: Koch’s postulates fulfilled for SARS virus. Nature. 423: 240
12. TG. Ksiazek, D. Erdman, CS. Goldsmith, SR. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, JA. Comer, W. Lim, PE. Rollin, SF. Dowell, AE. Ling, CD. Humphrey, WJ. Shieh, J. Guarner, CD. Paddock, P. Rota, B. Fields, J. DeRisi, JY. Yang, N. Cox, JM. Hughes, JW. LeDuc, WJ. Bellini, LJ. Anderson, and the SARS Working Group. (2003) A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 348(20): 1953-1966.
13. EJ. Snijder, PJ. Bredenbeek, JC. Dobbe, V. Thiel, J. Ziebuhr, LL. Poon, Y. Guan, M. Rozanov, WJ. Spaan, AE. Gorbalenya. (2003) Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol. 331(5): 991-1004.
14. MA. Marra, SJ. Jones, CR. Astell, RA. Holt, A. Brooks-Wilson, YS. Butterfield, J. Khattra, JK. Asano, SA. Barber, SY. Chan, A. Cloutier, SM. Coughlin, D. Freeman, N. Girn, OL. Griffith, SR. Leach, M. Mayo, H. McDonald, SB. Montgomery, PK. Pandoh, AS. Petrescu, AG. Robertson, JE. Schein, A. Siddiqui, DE. Smailus, JM. Stott, GS. Yang, F. Plummer, A. Andonov, H. Artsob, N. Bastien, K. Bernard, TF. Booth, D. Bowness, M. Czub, M. Drebot, L. Fernando, R. Flick, M. Garbutt, M. Gray, A. Grolla, S. Jones, H. Feldmann, A. Meyers, A. Kabani, Y. Li, S. Normand, U. Stroher, GA. Tipples, S. Tyler, R. Vogrig, D. Ward, B. Watson, RC. Brunham, M. Krajden, M. Petric, DM. Skowronski, C. Upton, RL. Roper. (2003) The genome sequence of the SARS-associated coronavirus. Science. 300(5624): 1399-1404.
15. J. Ziebuhr, EJ. Snijder, AE. Gorbalenya. (2000) Virus-encoded proteinases and proteolytic processing in the Nidovirales. J Gen Virol. 81: 853-879.
16. V. Thiel, KA. Ivanov, Á. Putics, T. Hertzig, B. Schelle, S. Bayer, B. Weißbrich, EJ. Snijder, H. Rabenau, HW. Doerr, AE. Gorbalenya, J. Ziebuhr. (2003) Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen Virol. 84: 2305-2315.
17. V. Thiel, J. Herold, B. Schelle, SG. Siddell. (2001) Viral replicase gene products suffice for coronavirus discontinuous transcription. J Virol. 75: 6676-6681.
18. TM. Gallagher. (2001) Murine coronavirus spike glycoprotein. Receptor binding and membrane fusion activities. Adv Exp Med Biol. 494: 183-192.
19. TM. Gallagher, MJ. Buchmeier. (2001) Coronavirus spike proteins in viral entry and pathogenesis. Virology. 279: 371-374.
20. KV. Holmes. (2003) SARS-associated coronavirus. N Engl J Med. 348(20): 1948-1951.
21. WH. Li, MJ. Moore, N. Vasilieva, JH. Sui, SK. Wong, MA. Berne, M. Somasundaran, JL. Sullivan, K. Luzuriaga, TC. Greenough, H. Choe , M. Farzan. (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 426: 450-454.
22. SK. Wong, WH. Li, MJ. Moore, H. Choe, M. Farzan. (2003) A 193-amino-acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J. Biol Chem. 279(5): 3197-3201.
23. J. Maeda, JF. Repass, A. Maeda, S. Makino. (2001) Membrane topology of coronavirus E protein. Virology. 15; 281(2): 163-169.
24. K. Narayanan, A. Maeda, J. Maeda, S. Makino. (2000) Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells. J Virol. 74(17): 8127-8134.
25. JG. Breman, DA. Henderson. (2002) Diagnosis and management of smallpox. N Engl J Med. 346(17): 1300-1308.
26. L. Baillie. (2001) The development of new vaccines against Bacillus anthracis. J Appl Microbiol. 91(4): 609-613.
27. SA. Plotkin. (2000) Rabies. Clin Infect Dis. 30(1): 4-12.
28. JD. Cherry, U. Heininger. Pertussis and other Bordetella infections. In: RD. Feigin, JD. Cherry, eds. (1998) Textbook of Pediatric Infectious Diseases. 4th ed. Philadelphia, PA: WB Saunders Co; 2:1423-1439
29. F. Winau, R. Winau. (2002) Emil von Behring and serum therapy. Microbes Infect. 4(2): 185-188.
30. HL. Robinson. (1997) Nucleic acid vaccines: an overview. Vaccine. 15(8): 785- 787.
31. JJ. Donnelly, JB. Ulmer, JW. Shiver, MA. Liu. (1997) DNA Vaccines. Annu Rev Immunol. 15:617-648.
32. B. Wang, AP. Godillot, MP. Madaio, DB. Weiner, WV. Williams. (1998) Vaccination against pathogenic cells by DNA inoculation. Curr Top Microbiol Immunol. 226: 21-35.
33. DC. Tang, M. Devit, SA. Johnson. (1992) Genetic immunization is a simple method for eliciting an immune response. Nature. 356: 152-154.
34. L. Vanderzanden, M. Bray, D. Fuller, T. Roberts, D. Custer, K. Spik, P. Jahrling, J. Huggins, A. Schmaljohn , C. Schmaljohn. (1998) DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge. Virology. 246(1): 134-144.
35. DK. Singh, Z. Liu, D. Sheffer, GA. Mackay, M. Smith, S. Dhillon, R. Hegde, F. Jia, I. Adany, O. Narayan. (2005) A noninfectious simian/human immuno- deficiency virus DNA vaccine that protects macaques against AIDS. J Virol. 79(6): 3419-3428.
36. AP. Wlazlo, H. Deng, W. Giles-Davis, HC. Ertl. (2004) DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteins. Cancer Gene Ther. 11(6): 457-464.
37. D. Wang, ME. Christopher, LP. Nagata, MA. Zabielski, H. Li, JP. Wong, J. Samuel. (2004) Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses. J Clin Virol. Suppl 1: S99-106.
38. G. Romano, P. Micheli, C. Pacilio, A. Giordano. (2000) Latest developments in gene transfer technology : achievements, perspectives, and controversies over therapeutic applications. Stem Cells. 18(1): 19-39.
39. CD. Rocha, BC. Caetano, AV. Machado, O. Bruña-Romero. (2004) Recombinant viruses as tools to induce protective cellular immunity against infectious diseases. Int Microbiol. 7(2): 83-94.
40. JL. Brandsma, M. Shlyankevich, L. Zhang, MaD. Slade, EC. Goodwin, W. Peh, AB. Deisseroth. (2004) Vaccination of rabbits with an adenovirus vector expressing the papillomavirus E2 protein leads to clearance of papillomas and infection. J Virol. 78(1): 116-123.
41. NL. Letvin, Y. Huang, BK. Chakrabarti, L. Xu, MS. Seaman, K. Beaudry, B. Korioth-Schmitz, F. Yu, D. Rohne, KL. Martin, A. Miura, WP. Kong, ZY. Yang, RS. Gelman, OG. Golubeva, DC. Montefiori, JR. Mascola, GJ. Nabel. (2004) Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys. J Virol. 78: 7490-7497.
42. S. Jaiswal, N. Khanna, S. Swaminathan. (2003) Replication-defective adenoviral vaccine vector for the induction of immune responses to dengue virus type 2. J Virol. 77(23): 12907-12913.
43. NJ. Sullivan, TW. Geisbert, JB. Geisbert, L. Xu, Z. Yang, M. Roederer, RA. Koup, PB. Jahrling, GJ. Nabel. (2003) Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature. 7;424(6949): 681-684.
44. WS. Gallichan, KL. Rosenthal. (1998) Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization. J Infect Dis. 177(5): 1155-1161.
45. M. Matsui, O. Moriya, T. Akatsuka. (2003) Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid. Vaccine. 21(15): 1629-1639.
46. L. Wu, W. Kong, GJ. Nabel. (2005) Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogens. J Virol. 79(13): 8024-8031.
47. P. Zhao, JS. Ke, ZL. Qin, H. Ren, LJ. Zhao, JG. Yu, J. Gao, SY. Zhu, ZT. Qi. (2004) DNA vaccine of SARS-CoV S gene induces antibody respose in mice. Acta Biochim et Biophysica Sinica. 36(1): 37-41.
48. A. Bukreyev, EW. Lamirande, UJ. Buchholz, LN. Vogel, WR. Elkins, MS. Claire, BR. Murphy, K. Subbarao, PL. Collins. (2004) Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet. 363: 2122-2127.
49. S. Xiong, YF. Wang, MY. Zhang, XJ. Liu, CH. Zhang, SS. Liu, CW. Qian, JX. Li, JH. Lu, ZY. Wan, HY. Zheng, XG. Yan, MJ. Meng, JL. Fan. (2004) Immunogenicity of SARS inactivated vaccine in BALB/c mice. Immunol Lett. 95: 139-143.
50. H. Pang, Y. Liu, X. Han, Y. Xu, F. Jiang, D. Wu, X. Kong, M. Bartlam, Z. Rao. (2004) Protective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccine. J Gen Virol. 85: 3109-3113.
51. Z. Chen, L. Zhang, C. Qin, L. Ba, CE. Yi, F. Zhang, Q. Wei, T. He, W. Yu, J. Yu, H. Gao, X. Tu, A. Gettie, M. Farzan, K. Yuen, DD. Ho. (2005) Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. J Virol. 79(5): 2678-2688.
52. W. Gao, A. Tamin, A. Soloff, L. D’Aiuto, E. Nwanegbo, PD Robbins, WJ. Bellini, S. Barratt-Boyes, A. Gambotto. (2003) Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet. 362: 1895-1896.
53. SH. Yeh, HY. Wang, CY. Tsai, CL. Kao, JY. Yang, HW. Liu, IJ. Su, SF. Tsai, DS. Chen, PJ. Chen, the National Taiwan University SARS Research Team. (2004) Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution. Proc Natl Acad Sci U S A. 101(8): 2542-2547.
54. H. Laude, J. Gelfi, L. Lavenant, B. Charley. (1992) Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus. J. Virol. 66(2): 743-749.
55. IM. Antón, S. González, MJ. Bullido, M. Corsín, C. Risco, JP. Langeveld, L. Enjuanes. (1996) Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodies. Virus Res. 46(1-2): 111-124.
56. A. Mandic, T. Vujkov. (2004) Human papillomavirus vaccine as a new way of preventing cervical cancer: a dream or the future? Ann Oncol. 15(2): 197-200.
57. L. Yuan, C. Iosef, MS. Azevedo, Y. Kim, Y. Qian, A. Geyer, TV. Nguyen, KO. Chang, LJ. Saif. (2001) Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs. J Virol. 75(19): 9229-9238.
58. SC. Gilbert, SJ Schneider, CM. Hannan, JT. Hu, M. Plebanski, R. Sinden, AV. Hill. (2002) Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes. Vaccine. 20(7-8): 1039-1045.
59. SH. Park, SH. Yang, CG Lee, JW Youn, J. Chang, YC. Sung. (2003) Efficient induction of T helper 1 CD4+ T-cell responses to hepatitis C virus core and E2 by a DNA prime-adenovirus boost. Vaccine. 21(31): 4555-4564.
60. ZY. Yang, LS Wyatt, WP. Kong, Z. Moodie, B. Moss, GJ Nabel. (2003) Overcoming immunity to a viral vaccine by DNA priming before vector boosting. J Virol. 77: 799-803.
61. Z. Wang, Z. Yuan, M. Matsumoto, UR. Hengge, YF. Chang. (2005) Immune responses with DNA vaccines encoded different gene fragments of severe acute respiratory syndrome coronavirus in BALB/c mice. Biochem Biophys Res Commun. 327(1): 130-135.
62. MS. Zhu, Y. Pan, HQ. Chen, Y. Shen, XC. Wang, YJ. Sun, KH. Tao. (2004) Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine. Immunol Lett. 92(3): 237-243. | en |